Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 68788-8511

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68788-8511). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Dr Cap 20mg (A9d05a38 08db 4710 B6f3 20c92ce885d5 00)

Label for Esomeprazole Magnesium DR Capsules, 20mg, generic for Nexium, manufactured by Dr Reddy's Laboratories Limited. The delayed-release capsules contain 20mg esomeprazole (as 22.3mg esomeprazole magnesium trihydrate USP). Includes storage instructions, batch and lot number fields, and directions for use in English and Spanish on a yellow background.*

FDA Label Image

Figure1 (Figure1)

Chemical structure diagram of Esomeprazole Magnesium showing molecular components including the pyridine and benzimidazole rings, sulfoxide group, magnesium ion, and associated water molecules (hydrate).*

FDA Label Image

Figure2 (Figure2)

A line graph depicting the percentage maintained over a six-month period comparing Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, 10 mg strengths, and placebo. The x-axis shows time in months, and the y-axis shows percent maintained from 0 to 100%. The graph illustrates the performance of each dosage strength and placebo over time.*

FDA Label Image

Figure3 (Figure3)

A line graph depicting the percent of a variable maintained over a 6-month period for four groups: Esomeprazole 40 mg, Esomeprazole 20 mg, Esomeprazole 10 mg, and placebo. The x-axis represents time in months from 1 to 6, and the y-axis shows percent maintained from 0 to 100. The Esomeprazole 40 mg and 20 mg groups maintain near 100%, Esomeprazole 10 mg shows a decline to about 70%, and placebo declines sharply to around 30% over time.*

FDA Label Image

Figure4 (Figure4)

A line graph depicting the percent of patients symptom-free over a 28-day diary period. It compares three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo, showing trends of symptom relief across time.*

FDA Label Image

Figure5 (Figure5)

A line graph depicting the percent of patients symptom-free over 28 days for three groups: Esomeprazole 40 mg, Esomeprazole 20 mg, and placebo. The x-axis represents the diary day from 0 to 28, and the y-axis shows the percent of patients symptom-free from 0 to 100%.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.